Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where ...

Three major drug middlemenneedlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 billion ...

Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January ...

Cigna Group closed $91.51 below its 52-week high ($370.83), which the company achieved on September 16th.

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.

The Cigna Group Inc. (NYSE: CI) is at the top of the health insurer food chain. The company has demonstrated its foresight ...

Fulton Bank N.A. lowered its stake in shares of The Cigna Group (NYSE:CI – Free Report) by 44.7% in the fourth quarter, ...